Jeymi was Chief Medical Officer at Genascence Corporation, and Senior Vice President, Clinical Development and External Innovation at Biosplice Therapeutics. Jeymi Tambiah joined Eupraxia Pharmaceuticals in 2026.
Jeymi Tambiah is currently
Create your alert
to follow the career of Jeymi Tambiah.
Jeymi Tambiah has a Master of Science Doctorate Degree, Immunology And Atherosclerosis from Imperial College London.
They have also studied at Imperial College London :
Find more alumni from Imperial College London
Do you need to know more about Jeymi Tambiah? More results.
Report an error
Update the org chart details of Jeymi Tambiah.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.